Sign in
4

Changes in Ownership

Citius Pharmaceuticals, Inc. Filed Acc 0001013762-23-003530

Options or other derivatives

  • Chief Financial Officer acquired 300,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Bartushak Jaime Chief Financial Officer 2023-10-10 Grant or award · Stock Option (Right to Purchase Common Stock) +300,000 300,000 D
Loading xslF345X05/ownership.xml…